Finance

Lists
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
A$0.062
-6.06%
(-0.0040) 1D
Aug 28, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
24.16M
Avg. vol.
206.77K
Volume
220.24K
52-wk high
A$0.19
52-wk low
A$0.06
EPS
-A$0.02
Shares outstanding
389.72M
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
24.16M
Avg. vol.
206.77K
Volume
220.24K
52-wk high
A$0.19
52-wk low
A$0.06
EPS
-A$0.02
Shares outstanding
389.72M
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
SectorBiotechnology
Websiteneuroscientific.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
158.95K
158.95K
-
-
Cost of goods sold
23.53K
23.53K
-
-
Cost of revenue
23.53K
23.53K
-
-
Research and development expenses
225.61K
225.61K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
409.06K
409.06K
-
-
Operating expense
1.04M
1.04M
-
-
Total operating expenses
1.07M
1.07M
1.49M
-
Operating income
-908.64K
-908.64K
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-849.71K
-849.71K
-
-
EBT excluding unusual items
-849.71K
-849.71K
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-849.71K
-849.71K
-1.50M
-1.50M
Net profit margin
-534.56%
-534.56%
-
-
Earnings per share
-
-
-
-
Interest and investment income
59.20K
59.20K
-
-
Interest expense
-263.00
-263.00
-
-
Net interest expenses
58.94K
58.94K
-60.77K
-
Depreciation and amortization charges
383.00
383.00
-
-
EBITDA
-597.26K
-597.26K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps